Therefore, we prospectively enrolled 39 patients to study the status of re‐biopsy and retrospectively analyzed 34 EGFR‐mutant patients, who were diagnosed with advanced NSCLC after failure to first‐line EGFR‐TKI treatment. Here, EGFR is linked to non-small cell lung carcinoma.